Trajan Wealth LLC increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 15.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 207,545 shares of the medical device company’s stock after purchasing an additional 28,276 shares during the period. Trajan Wealth LLC owned approximately 0.11% of Cooper Companies worth $17,010,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in COO. JANA Partners Management LP acquired a new stake in shares of Cooper Companies in the 3rd quarter valued at approximately $166,917,000. Rakuten Investment Management Inc. bought a new position in Cooper Companies during the 3rd quarter worth approximately $11,341,000. Alecta Tjanstepension Omsesidigt grew its holdings in Cooper Companies by 15.8% during the third quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after purchasing an additional 213,500 shares during the period. DAVENPORT & Co LLC increased its stake in Cooper Companies by 1,359.7% in the fourth quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after purchasing an additional 528,346 shares in the last quarter. Finally, Swiss Life Asset Management Ltd increased its stake in Cooper Companies by 63.9% in the third quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after purchasing an additional 19,264 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on COO shares. William Blair raised shares of Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Barclays upped their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Citigroup decreased their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research note on Friday, March 6th. Finally, Needham & Company LLC boosted their target price on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $90.79.
Cooper Companies Stock Up 0.5%
Cooper Companies stock opened at $61.75 on Thursday. The stock has a market capitalization of $12.05 billion, a PE ratio of 30.57, a price-to-earnings-growth ratio of 1.58 and a beta of 0.89. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The company has a 50 day moving average of $67.37 and a 200-day moving average of $75.28.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.03 by $0.07. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.
About Cooper Companies
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Stories
- Five stocks we like better than Cooper Companies
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
